BioSpace News Archive

Business

TRACON to Report Fourth Quarter and Full Year 2019 Financial Results and Company Highlights on February 27, 2020

SAN DIEGO, Feb. 20, 2020 (GLOBE NEWSWIRE) -- TRACON Pharmaceuticals (NASDAQ:TCON), a clinical stage biopharmaceutical company focused on the development and commercialization of novel targeted therapeutics for cancer and wet age-related macular degeneration through our license to Santen Pharmaceutical Co. Ltd., and utilizing our product development platform to partner with ex-U.S. companies to develop and commercialize innovative products in the U.S., announced today that it will report its fo

February 20, 2020
·
2 min read
Business

vTv Therapeutics Announces 2019 Fourth Quarter and Full Year Financial Results and Provides Corporate Update

Company Announced Positive Results from Its Phase 2 Type 1 Diabetes Trial Showing that TTP399 Lowered HbA1C, Decreased the Use of Insulin for Patients and Increased Time in Range

February 20, 2020
·
14 min read
Paragon 28® Adds Larger Implant Option to Help Address Hallux Malleus in their First-of-its-kind Hammertoe and Plantar Plate Repair Solution - TenoTac® Soft Tissue Fixation System

ENGLEWOOD, Colo. , Feb. 24, 2020 /PRNewswire/ -- Paragon 28® launched the TenoTac® Soft Tissue Fixation System in January 2019, providing surgeons the first and only dedicated system to address tendon transfers of the forefoot to correct contracted toes and repair plantar plate. In contrast to traditional methods for flexor tendon transfers, TenoTac® facilitates correction wit

February 20, 2020
·
2 min read